Pub. Date : 1986 Jul
PMID : 3086358
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation. | Levodopa | prolactin | Homo sapiens |
2 | Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation. | Levodopa | prolactin | Homo sapiens |
3 | Contrary to a previous report, pretreatment of normal men with carbidopa plus L-dopa (Sinemet 25/250) markedly inhibited the PRL response to TRH, a stimulus that acts directly on the pituitary. | Levodopa | prolactin | Homo sapiens |